Spectral Diagnostics (OTCMKTS:EDTXF) Stock Price Down 0.2% – Should You Sell?

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) traded down 0.2% during trading on Wednesday . The company traded as low as $0.94 and last traded at $0.94. 6,200 shares were traded during mid-day trading, an increase of 12% from the average session volume of 5,541 shares. The stock had previously closed at $0.9420.

Spectral Diagnostics Price Performance

The stock has a market capitalization of $275.83 million, a PE ratio of -9.40 and a beta of 0.11. The company’s 50 day moving average price is $0.99 and its two-hundred day moving average price is $0.99.

Spectral Diagnostics (OTCMKTS:EDTXF) last announced its quarterly earnings data on Friday, May 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $0.64 million for the quarter, compared to analysts’ expectations of $0.54 million.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.